France Travel Vaccine Market to 2032
Overview
The France Travel Vaccine Market is expected to reach a 387.71 USD Million by 2032 and is projected to grow at a CAGR of 11.42% from 2025 to 2032.
Revenue, 2024 (USD Million)
195.91
Forecast, 2032 (USD Million)
387.71
CAGR, 2024 - 2032
11.42%
Report Coverage
France
France Travel Vaccine Market 2018-2032 USD Million
France Travel Vaccine Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 195.91 USD Million
- Projected Market Size (2032): 387.71 USD Million
- CAGR (2025-2032): 11.42%
Key Findings of France Travel Vaccine Market
- The France Travel Vaccine Market was valued at 195.91 USD Million in 2024.
- The France Travel Vaccine Market is likely to grow at a CAGR of 11.42% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Injectable in Route of Administration Segment accounted for the largest share of the market with a revenue of 159.82 USD Million
- The fastest growing segment Typhoid in Disease Segment grew Fastest with a CAGR of 19.71% during the forecast period from 2024 to 2032.
France Travel Vaccine Market Scope
France Travel Vaccine Market Segmentation & Scope
Type
- Viral Vector Vaccines
- DNA Vaccines
- Toxoid Vaccines
- Live-Attenuated Vaccines
- Subunit, Recombinant, Polysaccharide and Conjugate Vaccines
- Inactivated Vaccines
Composition
- Mono Vaccines
- Combination Vaccines
Category
- Required Vaccine
- Routine Vaccine
- Recommended Vaccine
Route of Administration
- Oral
- Injectable
Disease
- COVID-19
- Others
- Polio
- Malaria
- Tick-Borne Encephalitis
- Measles and Mumps
- DPT
- Rabies
- Yellow Fever
- Meningococcal Meningitis
- Japanese Encephalitis
- Influenza
- Varicella
- Cholera
- Hepatitis
- Typhoid
Age Group
- Above 50 Years
- Less than 20 Years
- 20-50 Years
Distribution Channel
- B2C
- B2B
Patient Type
- Geriatric
- Pediatric
- Adult
Gender
- Female
- Male
France Travel Vaccine Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2022 |
| Unit | Revenue in USD Million |
| Market Value in 2024 | 195.91 USD Million |
| Market Value in 2032 | 387.71 USD Million |
| CAGR (2025-2032) | 11.42% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Type,Composition,Category,Route of Administration,Disease,Age Group,Distribution Channel,Patient Type,Gender |
Regional Insights:
-
Leading Market (2024-2032): France, leading in terms of revenue 195.91 USD Million in 2024
- Key Country: France, leading in terms of revenue with value of 195.91 USD Million in 2024.
Segments and Scope
-
France Travel Vaccine Market to 2032, By Type
- Inactivated Vaccines is the largest segment in France Travel Vaccine Market to 2032 with a revenue of 53.89 USD Million in the year 2024.
- Inactivated Vaccines is the Fastest growing segment in France Travel Vaccine Market to 2032 with a Growth rate of 12.59 % in forecast period 2025-2032.
-
France Travel Vaccine Market to 2032, By Composition
- Combination Vaccines is the largest segment in France Travel Vaccine Market to 2032 with a revenue of 133.88 USD Million in the year 2024.
- Combination Vaccines is the Fastest growing segment in France Travel Vaccine Market to 2032 with a Growth rate of 11.58 % in forecast period 2025-2032.
-
France Travel Vaccine Market to 2032, By Category
- Recommended Vaccine is the largest segment in France Travel Vaccine Market to 2032 with a revenue of 90.34 USD Million in the year 2024.
- Recommended Vaccine is the Fastest growing segment in France Travel Vaccine Market to 2032 with a Growth rate of 11.85 % in forecast period 2025-2032.
-
France Travel Vaccine Market to 2032, By Route of Administration
- Injectable is the largest segment in France Travel Vaccine Market to 2032 with a revenue of 159.82 USD Million in the year 2024.
- Injectable is the Fastest growing segment in France Travel Vaccine Market to 2032 with a Growth rate of 11.57 % in forecast period 2025-2032.
-
France Travel Vaccine Market to 2032, By Disease
- Typhoid is the largest segment in France Travel Vaccine Market to 2032 with a revenue of 31.06 USD Million in the year 2024.
- Typhoid is the Fastest growing segment in France Travel Vaccine Market to 2032 with a Growth rate of 19.71 % in forecast period 2025-2032.
-
France Travel Vaccine Market to 2032, By Age Group
- 20-50 Years is the largest segment in France Travel Vaccine Market to 2032 with a revenue of 96.39 USD Million in the year 2024.
- 20-50 Years is the Fastest growing segment in France Travel Vaccine Market to 2032 with a Growth rate of 11.90 % in forecast period 2025-2032.
-
France Travel Vaccine Market to 2032, By Distribution Channel
- B2B is the largest segment in France Travel Vaccine Market to 2032 with a revenue of 151.08 USD Million in the year 2024.
- B2B is the Fastest growing segment in France Travel Vaccine Market to 2032 with a Growth rate of 11.59 % in forecast period 2025-2032.
-
France Travel Vaccine Market to 2032, By Patient Type
- Adult is the largest segment in France Travel Vaccine Market to 2032 with a revenue of 87.54 USD Million in the year 2024.
- Adult is the Fastest growing segment in France Travel Vaccine Market to 2032 with a Growth rate of 12.08 % in forecast period 2025-2032.
-
France Travel Vaccine Market to 2032, By Gender
- Male is the largest segment in France Travel Vaccine Market to 2032 with a revenue of 101.84 USD Million in the year 2024.
- Male is the Fastest growing segment in France Travel Vaccine Market to 2032 with a Growth rate of 11.65 % in forecast period 2025-2032.
France Travel Vaccine Market Company Share Analysis
| Company Name |
|
||
| Merck & Co., Inc. | |||
| Johnson & Johnson Services, Inc. | |||
| Pfizer Inc. | |||
| Sanofi | |||
| GSK plc. | |||
France Travel Vaccine Market Geographical Sales Distribution, 2018-2032 USD Million
France Travel Vaccine Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The France Travel Vaccine Market is segmented based on Segmentation Type,Composition,Category,Route of Administration,Disease,Age Group,Distribution Channel,Patient Type,Gender.
France Travel Vaccine Market was valued at USD 195.91(Revenue in USD Million) in 2022.
France Travel Vaccine Market is projected to grow at a CAGR of 11.42% during the forecast period of 2024 to 2032.
The Injectable segment is expected to dominate the France Travel Vaccine Market, holding a largest market share of 159.82 USD Million in 2024
France Travel Vaccine Market Scope
France Travel Vaccine Market Segmentation & Scope
Type
- Viral Vector Vaccines
- DNA Vaccines
- Toxoid Vaccines
- Live-Attenuated Vaccines
- Subunit, Recombinant, Polysaccharide and Conjugate Vaccines
- Inactivated Vaccines
Composition
- Mono Vaccines
- Combination Vaccines
Category
- Required Vaccine
- Routine Vaccine
- Recommended Vaccine
Route of Administration
- Oral
- Injectable
Disease
- COVID-19
- Others
- Polio
- Malaria
- Tick-Borne Encephalitis
- Measles and Mumps
- DPT
- Rabies
- Yellow Fever
- Meningococcal Meningitis
- Japanese Encephalitis
- Influenza
- Varicella
- Cholera
- Hepatitis
- Typhoid
Age Group
- Above 50 Years
- Less than 20 Years
- 20-50 Years
Distribution Channel
- B2C
- B2B
Patient Type
- Geriatric
- Pediatric
- Adult
Gender
- Female
- Male
Frequently Asked Questions
The France Travel Vaccine Market is segmented based on Segmentation Type,Composition,Category,Route of Administration,Disease,Age Group,Distribution Channel,Patient Type,Gender.
France Travel Vaccine Market was valued at USD 195.91(Revenue in USD Million) in 2022.
France Travel Vaccine Market is projected to grow at a CAGR of 11.42% during the forecast period of 2024 to 2032.
The estimated market value of the France Travel Vaccine Market for final year is USD 387.71 (USD Million).
France Travel Vaccine Market Company Profiling
Frequently Asked Questions
The France Travel Vaccine Market is segmented based on Segmentation Type,Composition,Category,Route of Administration,Disease,Age Group,Distribution Channel,Patient Type,Gender.
France Travel Vaccine Market was valued at USD 195.91(Revenue in USD Million) in 2022.
France Travel Vaccine Market is projected to grow at a CAGR of 11.42% during the forecast period of 2024 to 2032.
The estimated market value of the France Travel Vaccine Market for final year is USD 387.71 (USD Million).
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.